A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Paralysed man regains feeling and movement with AI brain implant
Micron Says Half of Sales Tied to China-HQ Clients at Risk
This plug-and-play microphone is just $35 for Labor Day
Students: Slide into Summer Break Without Risking the Summer Slide
UK, US and other governments release rules to stop AI being hijacked by rogue actors
Russian cyber-attacks ‘relentless’ as threat of WW3 grows, expert warns
Glencore Bets on US Love of Coal With New Fossil Fuel Giant
Congress Wades Into Self-Driving Debate With New US House Bills